angiotensin ii, des-phe(8)- has been researched along with Atherogenesis in 25 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (4.00) | 29.6817 |
2010's | 23 (92.00) | 24.3611 |
2020's | 1 (4.00) | 2.80 |
Authors | Studies |
---|---|
Białas, M; Bujak-Giżycka, B; Jawień, J; Kiepura, A; Kuś, K; Olszanecki, R; Stachowicz, A; Stachyra, K; Suski, M; Totoń-Żurańska, J; Wiśniewska, A; Łomnicka, M | 1 |
Grandoch, M; Hendgen-Cotta, U; Hering, L; Höges, S; Istas, G; Mergia, E; Rassaf, T; Rodriguez-Mateos, A; Rump, LC; Stegbauer, J; Yakoub, M; Yang, G | 1 |
Campagnole-Santos, MJ; Carvalho Santuchi, M; da Silva, RF; de Morais E Silva, M; de Souza-Neto, FP | 1 |
Dong, M; Gao, F; Hao, PP; Li, JJ; Liu, XL; Meng, X; Wang, XP; Yang, JM; Yang, XY; Zhang, C; Zhang, K; Zhang, MX; Zhang, Y; Zhao, XQ; Zhao, YX | 1 |
Bujak-Gizycka, B; Gebska, A; Jawien, J; Korbut, R; Kus, K; Madej, J; Olszanecki, R; Suski, M; Toton-Zuranska, J | 1 |
Clasen, T; Fähling, M; Ishak, B; Kojda, G; Mende, S; Patzak, A; Potthoff, SA; Rump, LC; Sivritas, SH; Stamer, S; Stegbauer, J; Suvorava, T; Thieme, M | 1 |
Alsaadon, H; Habiyakare, B; Hayes, A; Mathai, ML; Zulli, A | 1 |
Bai, R; Bian, Y; Liang, B; Liu, M; Wang, X; Xiao, C; Yang, H; Yang, Z | 1 |
Chen, X; Dong, B; Dong, XF; Hao, QQ; Li, SY; Tengbeh, AF; Yu, QT; Zhang, Y; Zhang, YH; Zhou, XM | 1 |
Bian, YF; Gao, F; Liang, B; Xiao, CS; Yang, HY; Yang, ZM; Zhang, N | 1 |
Chlopicki, S; Kij, A; Olkowicz, M; Radulska, A; Smolenski, RT; Suraj, J; Walczak, M | 1 |
Dong, M; Guan, J; Meng, X; Niu, R; Sun, Y; Yang, J; Yang, X; Zhang, C; Zhang, Y | 1 |
da Silva, CHTP; de Oliveira, AM; do Prado, AF; Gerlach, RF; Gomes, MS; Pernomian, L | 1 |
Chang, Q; Chen, LJ; Jin, HY; Oudit, GY; Song, B; Xu, R; Xu, YL; Yu, HM; Zhang, ZZ; Zhong, JC; Zhu, DL | 1 |
Chen, W; Hao, P; Li, H; Li, J; Li, W; Meng, X; Yang, J; Zhang, C; Zhang, Y | 1 |
Apostolopoulos, V; Qaradakhi, T; Zulli, A | 1 |
Czesnikiewicz-Guzik, M; Guzik, TJ; Jawien, J; Korbut, R; Mikolajczyk, TP; Montezano, AC; Nosalski, R; Olszanecki, R; Rios, FJ; Siedlinski, M; Skiba, DS; Touyz, RM | 1 |
Chen, H; Cui, Y; Li, S; Liu, J; Song, J; Zhang, F | 1 |
Casley, D; Gaspari, TA; Tesanovic, S; Vinh, A; Widdop, RE | 1 |
Hayashi, N; Iwamoto, Y; Oguro, R; Ohishi, M; Rakugi, H; Shiota, A; Takeda, M; Takeya, Y; Tatara, Y; Yamamoto, K | 1 |
Cassis, LA; Daugherty, A; Gurley, SB; Howatt, DA; Lu, H; Thatcher, SE; Zhang, X | 1 |
Clasen, T; Friedrich, S; Königshausen, E; Mergia, E; Potthoff, SA; Quack, I; Rump, LC; Sellin, L; Stegbauer, J; Vonend, O; Woznowski, M | 1 |
Gajda, M; Gebska, A; Guzik, TJ; Jawien, J; Korbut, R; Kus, K; Marcinkiewicz, J; Niepsuj, A; Nowak, B; Olszanecki, R; Pyka-Fosciak, G; Suski, M; Toton-Zuranska, J | 1 |
Chan, K; Chen, H; Ren, J; Zhang, F | 1 |
Deng, BP; Dong, B; Dong, QL; Feng, JB; Li, SY; Liu, B; Liu, CX; Pan, CM; Song, HD; Yang, YP; Yu, QT; Zhang, C; Zhang, MX; Zhang, Y; Zhao, YX; Zhu, L | 1 |
2 review(s) available for angiotensin ii, des-phe(8)- and Atherogenesis
Article | Year |
---|---|
Angiotensin-(1-7) and Alamandine on Experimental Models of Hypertension and Atherosclerosis.
Topics: Angiotensin I; Animals; Atherosclerosis; Humans; Hypertension; Models, Theoretical; Oligopeptides; Peptide Fragments; Renin-Angiotensin System; Vasodilation | 2018 |
Angiotensin (1-7) and Alamandine: Similarities and differences.
Topics: Angiotensin I; Animals; Atherosclerosis; Endothelium, Vascular; Humans; Nitric Oxide; Oligopeptides; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction; Vasodilation; Vasodilator Agents | 2016 |
23 other study(ies) available for angiotensin ii, des-phe(8)- and Atherogenesis
Article | Year |
---|---|
Diminazene Aceturate Stabilizes Atherosclerotic Plaque and Attenuates Hepatic Steatosis in apoE-Knockout Mice by Influencing Macrophages Polarization and Taurine Biosynthesis.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Apolipoproteins E; Atherosclerosis; Diet, High-Fat; Diminazene; Disease Models, Animal; Fatty Liver; Female; Gene Expression Regulation; Humans; Liver; Macrophage Activation; Macrophages; Mesenteric Arteries; Mice; Mice, Inbred C57BL; Mice, Knockout, ApoE; Peptide Fragments; Plaque, Atherosclerotic; Taurine; THP-1 Cells | 2021 |
Angiotensin-(1-7)-induced Mas receptor activation attenuates atherosclerosis through a nitric oxide-dependent mechanism in apolipoproteinE-KO mice.
Topics: Angiotensin I; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Blood Pressure; Cyclic GMP; Male; Mice; Mice, Inbred C57BL; Mice, Knockout, ApoE; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Vasodilation | 2018 |
Angiotensin-(1-7) dose-dependently inhibits atherosclerotic lesion formation and enhances plaque stability by targeting vascular cells.
Topics: Angiotensin I; Animals; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Blood Pressure; Body Weight; Cell Movement; Cell Proliferation; Collagen; Dose-Response Relationship, Drug; Lipids; Macrophages; Matrix Metalloproteinases; Mice; Mice, Knockout; Microfilament Proteins; Muscle Proteins; Muscle, Smooth, Vascular; Peptide Fragments; Receptor, Angiotensin, Type 2; RNA, Messenger; Vasodilator Agents | 2013 |
The influence of angiotensin-(1-7) peptidomimetic (AVE 0991) and nebivolol on angiotensin I metabolism in aorta of apoE-knockout mice.
Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Aorta, Thoracic; Apolipoproteins E; Atherosclerosis; Benzopyrans; Down-Regulation; Drug Therapy, Combination; Ethanolamines; Female; Imidazoles; Mice; Mice, Inbred C57BL; Mice, Knockout; Nebivolol; Peptide Fragments; Renin-Angiotensin System; Vasodilator Agents | 2013 |
Angiotensin-(1-7) modulates renal vascular resistance through inhibition of p38 mitogen-activated protein kinase in apolipoprotein E-deficient mice.
Topics: Angiotensin I; Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Blood Pressure; Disease Models, Animal; Female; Hypertension, Renal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Naphthalenes; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Protein Kinase Inhibitors; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pyrazoles; Receptors, G-Protein-Coupled; Renal Circulation; Vascular Resistance | 2014 |
Reduction of angiotensin A and alamandine vasoactivity in the rabbit model of atherogenesis: differential effects of alamandine and Ang(1-7).
Topics: Acetylcholine; Angiotensin I; Angiotensins; Animals; Aorta, Abdominal; Aorta, Thoracic; Atherosclerosis; Carotid Arteries; Disease Models, Animal; Dose-Response Relationship, Drug; Iliac Artery; Male; Nitric Oxide Synthase Type III; Oligopeptides; Peptide Fragments; Phenylephrine; Rabbits; Receptors, G-Protein-Coupled; Renal Artery; Vasoconstriction; Vasodilation | 2014 |
Angiotensin-(1-7) upregulates expression of adenosine triphosphate-binding cassette transporter A1 and adenosine triphosphate-binding cassette transporter G1 through the Mas receptor through the liver X receptor alpha signalling pathway in THP-1 macrophag
Topics: Angiotensin I; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP Binding Cassette Transporter, Subfamily G, Member 1; ATP-Binding Cassette Transporters; Cell Line, Tumor; Cholesterol; Humans; Liver X Receptors; Macrophages; Membrane Transport Proteins; Orphan Nuclear Receptors; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Up-Regulation | 2014 |
ACE2 and Ang-(1-7) protect endothelial cell function and prevent early atherosclerosis by inhibiting inflammatory response.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Apolipoproteins E; Atherosclerosis; Cell Adhesion; Cell Movement; Chemokine CCL2; Disease Models, Animal; E-Selectin; Endothelium, Vascular; Gene Transfer Techniques; Humans; In Vitro Techniques; Inflammation; Mice; Peptide Fragments; Peptidyl-Dipeptidase A; Signal Transduction; Vascular Cell Adhesion Molecule-1 | 2015 |
Angiotensin-(1-7) stimulates cholesterol efflux from angiotensin II-treated cholesterol-loaded THP-1 macrophages through the suppression of p38 and c-Jun N-terminal kinase signaling.
Topics: Angiotensin I; Angiotensin II; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP Binding Cassette Transporter, Subfamily G, Member 1; ATP-Binding Cassette Transporters; Cholesterol; Gene Expression Regulation, Enzymologic; Humans; JNK Mitogen-Activated Protein Kinases; Liver X Receptors; Macrophages; Orphan Nuclear Receptors; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; PPAR gamma; Renin-Angiotensin System; RNA, Messenger | 2015 |
Development of a sensitive, accurate and robust liquid chromatography/mass spectrometric method for profiling of angiotensin peptides in plasma and its application for atherosclerotic mice.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Angiotensins; Animals; Apolipoproteins E; Atherosclerosis; Chromatography, Liquid; Mass Spectrometry; Mice, Inbred C57BL; Mice, Knockout; Peptide Fragments; Receptors, LDL | 2015 |
Comparison of angiotensin-(1-7), losartan and their combination on atherosclerotic plaque formation in apolipoprotein E knockout mice.
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Abdominal; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Blood Pressure; Cell Line; Cell Movement; Cell Proliferation; Diet, High-Fat; Disease Models, Animal; Drug Therapy, Combination; Endothelium, Vascular; Humans; Lipids; Losartan; Macrophages; Male; Mice, Knockout; Muscle, Smooth, Vascular; Peptide Fragments; Plaque, Atherosclerotic; Renin-Angiotensin System; Superoxides; Time Factors; Vasodilation | 2015 |
MAS receptors mediate vasoprotective and atheroprotective effects of candesartan upon the recovery of vascular angiotensin-converting enzyme 2-angiotensin-(1-7)-MAS axis functionality.
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Aorta, Thoracic; Apolipoproteins E; Atherosclerosis; Benzimidazoles; Biphenyl Compounds; Cardiotonic Agents; Cholesterol; Cytokines; Male; Mice, Inbred C57BL; Mice, Knockout; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Tetrazoles; Triglycerides; Vascular Cell Adhesion Molecule-1 | 2015 |
Angiotensin-converting enzyme 2 ameliorates renal fibrosis by blocking the activation of mTOR/ERK signaling in apolipoprotein E-deficient mice.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Apolipoproteins E; Atherosclerosis; Fibrosis; Kidney; Kidney Diseases; Male; MAP Kinase Signaling System; Mice, Inbred C57BL; Mice, Knockout; Peptide Fragments; Peptidyl-Dipeptidase A; Sirolimus; TOR Serine-Threonine Kinases | 2016 |
Imbalance between angiotensin II and angiotensin-(1-7) in human coronary atherosclerosis.
Topics: Angiotensin I; Angiotensin II; Atherosclerosis; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Peptide Fragments; Tumor Necrosis Factor-alpha | 2016 |
Anti-atherosclerotic effect of the angiotensin 1-7 mimetic AVE0991 is mediated by inhibition of perivascular and plaque inflammation in early atherosclerosis.
Topics: Angiotensin I; Animals; Anti-Inflammatory Agents; Aorta; Atherosclerosis; Cell Line; Cell Line, Tumor; Cytokines; Female; Humans; Imidazoles; Leukocytes; Macrophages; Mice, Inbred C57BL; Mice, Knockout, ApoE; Peptide Fragments; Plaque, Atherosclerotic; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled | 2017 |
Angiotensin-(1-7) regulates angiotensin II-induced matrix metalloproteinase-8 in vascular smooth muscle cells.
Topics: Angiotensin I; Angiotensin II; Animals; Atherosclerosis; Cells, Cultured; Disease Models, Animal; Enzyme Activation; Humans; Matrix Metalloproteinase 8; Mice, Knockout, ApoE; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Plaque, Atherosclerotic; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Time Factors | 2017 |
Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice.
Topics: Acetylcholine; Angiotensin I; Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Endothelium, Vascular; Imidazoles; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Nitric Oxide Synthase Type III; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pyridines; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Superoxides; Time Factors; Vasodilation; Vasodilator Agents | 2010 |
The counterregulating role of ACE2 and ACE2-mediated angiotensin 1-7 signaling against angiotensin II stimulation in vascular cells.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Atherosclerosis; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Enzyme Inhibitors; Humans; Imidazoles; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Monocytes; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Peptide Fragments; Peptides; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Receptors, G-Protein-Coupled; Tetrazoles | 2010 |
Angiotensin-converting enzyme 2 deficiency in whole body or bone marrow-derived cells increases atherosclerosis in low-density lipoprotein receptor-/- mice.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Atherosclerosis; Bone Marrow Cells; Bone Marrow Transplantation; Cell Adhesion; Cells, Cultured; Coculture Techniques; Culture Media, Conditioned; Cytokines; Dietary Fats; Disease Models, Animal; Endothelial Cells; Humans; Inflammation Mediators; Losartan; Macrophages; Male; Mice; Mice, Knockout; Monocytes; Peptide Fragments; Peptidyl-Dipeptidase A; Receptors, LDL | 2011 |
Chronic treatment with angiotensin-(1-7) improves renal endothelial dysfunction in apolipoproteinE-deficient mice.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Apolipoproteins E; Atherosclerosis; Cyclic GMP; Dose-Response Relationship, Drug; Endothelium, Vascular; Hydrogen Peroxide; Infusion Pumps, Implantable; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Peptide Fragments; Perfusion; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Vasodilation | 2011 |
Angiotensin-(1-7) receptor Mas agonist ameliorates progress of atherosclerosis in apoE-knockout mice.
Topics: Angiotensin I; Animals; Antigens, CD; Aorta; Apolipoproteins E; Atherosclerosis; CD4-Positive T-Lymphocytes; Dendritic Cells; Female; Imidazoles; Lipids; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptide Fragments; Perindopril; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, Angiotensin; Receptors, G-Protein-Coupled; Thiorphan | 2012 |
Angiotensin-(1-7) regulates Angiotensin II-induced VCAM-1 expression on vascular endothelial cells.
Topics: Angiotensin I; Angiotensin II; Atherosclerosis; Cell Line; Endothelium, Vascular; Humans; NF-kappa B; Peptide Fragments; Protein Transport; Receptors, G-Protein-Coupled; Vascular Cell Adhesion Molecule-1 | 2013 |
Overexpression of ACE2 enhances plaque stability in a rabbit model of atherosclerosis.
Topics: Adenoviridae; Angioplasty, Balloon; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Aorta, Abdominal; Atherosclerosis; Cell Line; Cells, Cultured; Collagen; Diet, Atherogenic; Dietary Fats; Disease Models, Animal; Disease Progression; Genetic Vectors; Humans; Mice; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rabbits; Receptors, G-Protein-Coupled; Time Factors; Transduction, Genetic; Up-Regulation | 2008 |